287 related articles for article (PubMed ID: 17222324)
1. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial.
Spahr L; Coeytaux A; Giostra E; Hadengue A; Annoni JM
Am J Gastroenterol; 2007 Apr; 102(4):744-53. PubMed ID: 17222324
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.
Schmid M; Peck-Radosavljevic M; König F; Mittermaier C; Gangl A; Ferenci P
Liver Int; 2010 Apr; 30(4):574-82. PubMed ID: 20456040
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
Sussman G; Jancelewicz Z
Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
[TBL] [Abstract][Full Text] [Related]
4. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
[TBL] [Abstract][Full Text] [Related]
5. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.
Montagnese S; Middleton B; Skene DJ; Morgan MY
Liver Int; 2009 Oct; 29(9):1372-82. PubMed ID: 19686311
[TBL] [Abstract][Full Text] [Related]
6. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study.
Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P
Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
[TBL] [Abstract][Full Text] [Related]
8. Increased density of brain histamine H(1) receptors in rats with portacaval anastomosis and in cirrhotic patients with chronic hepatic encephalopathy.
Lozeva V; Tuomisto L; Sola D; Plumed C; Hippeläinen M; Butterworth R
Hepatology; 2001 Jun; 33(6):1370-6. PubMed ID: 11391525
[TBL] [Abstract][Full Text] [Related]
9. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
10. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
[TBL] [Abstract][Full Text] [Related]
11. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
12. A preliminary randomised double-blind placebo-controlled clinical trial of hydroxyzine for treating sleep bruxism in children.
Ghanizadeh A; Zare S
J Oral Rehabil; 2013 Jun; 40(6):413-7. PubMed ID: 23550945
[TBL] [Abstract][Full Text] [Related]
13. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
[TBL] [Abstract][Full Text] [Related]
14. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
[TBL] [Abstract][Full Text] [Related]
15. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.
Sant GR; Propert KJ; Hanno PM; Burks D; Culkin D; Diokno AC; Hardy C; Landis JR; Mayer R; Madigan R; Messing EM; Peters K; Theoharides TC; Warren J; Wein AJ; Steers W; Kusek JW; Nyberg LM;
J Urol; 2003 Sep; 170(3):810-5. PubMed ID: 12913705
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of sleep disturbance in cirrhosis.
Córdoba J; Cabrera J; Lataif L; Penev P; Zee P; Blei AT
Hepatology; 1998 Feb; 27(2):339-45. PubMed ID: 9462628
[TBL] [Abstract][Full Text] [Related]
17. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
[TBL] [Abstract][Full Text] [Related]
18. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
Saji S; Kumar S; Thomas V
Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
[TBL] [Abstract][Full Text] [Related]
19. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
Salo OP; Harvey SG; Calthrop JG; Gibson JR
J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
[TBL] [Abstract][Full Text] [Related]
20. Individual differences in central nervous system response to antihistamines (H1-receptor antagonists).
Simons FE; Fraser TG; Reggin JD; Simons KJ
Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):507-14. PubMed ID: 8603281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
